PREVALENCE OF ILD SUBTYPES ON THE BASIS OF HRCT AT A TERTIARY CARE HOSPITAL.

Humaira Anjum; Hussain Ahmad; Mahnoor Rehman; Hina Gul

PREVALENCE OF ILD SUBTYPES ON THE BASIS OF HRCT AT A TERTIARY CARE HOSPITAL.

Humaira Anjum, Hussain Ahmad, Mahnoor Rehman, Hina Gul

Abstract

ABSTRACT

Background: Interstitial Lung Diseases (ILDs) are a group of respiratory disorders, usually chronic and progressive in nature, primarily affecting the lung parenchyma leading to reduced gas exchange. The frequency of its subtypes is variable in different regions.

Objective: To determine the prevalence of ILD subtypes in our set up on the basis of HRCT.

Materials and Methods: This was a retrospective observational study conducted at Radiology Department of Khyber Teaching Hospital Peshawar from 1st July 2014 till 30^th June 2019. All HRCTs done during these five years were included for assessment of different subtypes of ILD. Scans with diagnosis other than ILD were excluded. The subtypes of ILD included were idiopathic Pulmonary Fibrosis (IPF), Non Specific Interstitial Pneumonia (NSIP), Hypersensitivity Pneumonitis (HP), Sarcoidosis, Connective Tissue Disease related ILD (CTD-ILD) and others. Patient’s age, gender and ILD subtypes were recorded in a Proforma. Data was analyzed via spss 19. Results were presented as graphs.

Results: Of the 632 scans reviewed, 171(27%) met the inclusion criteria. The mean age of patients was 51.5±18.9 years and 89 (56.9%) of the patients were females. The most common Subtype of ILD was IPF 28.16 %(n=49), followed by NSIP 25.29% (n=44), HP 13.79%(n=24), CTD-ILD 9.77%(n=17), and Sarcoidosis 7.47%(n=13). Other ILDs collectively constituted 15% of the subtypes. Conclusion: IPF was found to be the most common ILD, followed by NSIP, HP, CTD-ILD and sarcoidosis. Multidisciplinary approach and larger multicenter studies are required for better understanding of its etiology and management.

Key words: idiopathic pulmonary fibrosis, idiopathic interstitial pneumonia, hypersensitivity pneumonitis, Sarcoidosis, connective tissue disease.

Full Text:

PDF

References

Cushley MJ, Davison AG, duBois RM, Egan J, Flower CD, Gibson GJ, et al. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Thorax 1999; 54:S1S30.

Snell N, Strachan D, Hubbard R, Gibson J, Maher T, Jarrod I. Epidemiology of idiopathic pulmonary fibrosis in the UK: findings from the British lung foundation’s ‘respiratory health of the nation’ project. BMJ 2016; 71:209-33.

King TE, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet (London, Engl).2011; 378(9807):1949-61.

Hubbard R, Venn A, Smith C, Cooper M, Johnston I, Britton J. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case–control study. Am J Respir Crit Care Med. 1998; 157:743-47.

Meyer KC, Raghu G. Patient evaluation. In: Baughman RP, Du Bois RM, editors. Interstitial Lung Disease: A Practical Approach. Second. New York: Springer; 2011:3–16.

Kanne JP. Interstitial lung disease (ILD): imaging finding, and the role of imaging in evaluating the patient with known or suspected ILD. Semin Roentgenol. 2010; 45:3.

Hunninghake GW, Zimmerman MB, Schwartz DA, King TE, Lynch J, Hegele R, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2001 Jul 15;164(2):193-6.

Honda O, Johkoh T, Ichikado K, Yoshida S, Mihara N, Higashi M, et al. Comparison of high resolution CT findings of sarcoidosis, lymphoma, and lymphangitic carcinoma: is there any difference of involved interstitium? J Comput Assist Tomogr. 1999 May-Jun; 23(3):374-9.

Bonelli FS, Hartman TE, Swensen SJ, Sherrick A .Accuracy of high-resolution CT in diagnosing lung diseases. Am J Roentgenol. 1998 Jun; 170(6):1507-12.

Thomeer MJ, Costabe U, Rizzato G, Poletti V, Demedts M. Comparison of registries of interstitial lung diseases in three European countries. Eur Resp J. 2001; 32:114s-8s.

Singh V, Sharma BB. Laying the ground for research of interstitial lung disease in our country: ILD India registry. Lung India 2014; 31: 320-2).

Ansari M, Naseem A, Ahmed R, Azeemuddin M. Profile of interstitial lung diseases in Pakistan, Karachi pulmonology clinics registry data 2008 - 11. Eur Respir J. 2012; 40 (56).

Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med.1994; 150:967-72.

Behr J, Kreuter M, Hoeper MH. Management of patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry. The Eur Respir J. 2015; 46(1):186–196.

Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. European Respiratory Review 2012; 21: 355-361.

Esam H. Alhamad. Interstitial lung diseases in Saudi Arabia: A single-center study. Ann Thorac Med. 2013 Jan-Mar; 8(1): 33–37.

Karakatsani A, Papakosta D, Rapti A, Antoniou KM, Dimadi M, Markopoulou A, et al. Epidemiology of interstitial lung diseases in Greece. Respir Med. 2009; 103(8):1122–9.

Singh S, Collins BF, Sharma BB, Joshi JM, Talwar D, Katiyar S, et al. Interstitial Lung Disease in India. Results of a Prospective Registry. Am J Respir Crit Care Med. 2017; 195(6):801–13.

Sarwar Zubairi AB, Hassan M, Shahzad T, Sarwar S, Abbas A, Ahmad H, et al. Spectrum of interstitial lung disease from a tertiary care hospital in Karachi. J Pak Med Assoc. 2017 Jul; 67(7):1065-69.

Kim DS, Collard HR, King TE. Classification and natural history of idiopathic interstitial pneumonias. Proc Am Thorac Soc. 2006; 3(4):285–92.

MacDonald SL, Rubens MB, Hansell DM. NSIP and UIP: Comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001;221:600-5.

Jindal SK and Gupta D. Incidence and recognition of interstitial pulmonary fibrosis in developing countries. Curr Opin Pulm Med. 1997; 3(5): 378–83.

Kreuter M, Herth FJ, Wacker M, Leidl R, Hellmann A, Pfeifer M, et al. Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry--The EXCITING-ILD Registry. BioMed research international 2015; 12:38-76.

Antoniou KM, Margaritopoulos G, Economidou F, Siafakas NM. Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement. Eur Respir J. 2009 Apr; 33(4):882-96.

Musellim B, Okumus G, Uzaslan E, Akgun M, Cetinkaya E, Turan O, et al. Epidemiology and distribution of interstitial lung diseases in Turkey. Clin Respir J. 2014; 8(1):55–62.

……………………………

Refbacks

There are currently no refbacks.